warning

Alert: Because flu cases are on the rise, children 12 and younger will be restricted from visiting hospitals and certain inpatient facilities. Learn more.

Research and Clinical Trials

Title  
Pharmacyclics PCYC-1134M-CA: informCLL: A Disease Registry for Patients with Chronic Lymphocytic Leukemia
Brief Description  
Primary: Describe current treatment patterns in the real-world setting of CLL patients who are initiating treatment with novel therapies including oral kinase inhibitors or other approved anti-CLL therapies/ regimens as 1st or later line of therapy. Explore association with baseline characteristics, healthcare resource utilization and clinical outcomes. Secondary: Characterize adverse events (AEs) ain CLL patients in this setting. Assess patient reported HRQOL and association with therapeutic
Who may be Eligible  
Please contact us for eligibility criteria.
Speciality/Disorder  
Leukemia, not otherwise specified
Status  
OPEN
Start Date  
02/09/2017
Principal Investigator  
Ghosh, Nilanjan
Contact Name  
Kathryn Marrogy

For More Information, Contact  Kathryn  , Marrogy
Phone:  980-442-2343 Fax:    
Email:  kathryn.marrogy@carolinashealthcare.org
Address:1021 Morehead Medical Drive Suite 2200 Charlotte, 28204
Close